Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | GLS | O94925 | 1/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | CFD | P00746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3760044 | 0.92 | L3MBTL1 (0.43) | MAOBNOS1NOS2PNMTENPP2 | |
| SCHEMBL3766432 | 0.90 | GLS (0.42) | MAOBNOS1NOS2KDM4EGLS | |
| SCHEMBL3759807 | 0.89 | PRSS1 (0.42) | MAOBNOS1NOS2KDM4EGLS | |
| SCHEMBL3764561 | 0.89 | PRSS1 (0.42) | MAOBNOS1NOS2KDM4EGLS | |
| SCHEMBL7855553 | 0.85 | GLS (0.41) | KDM4EBCHEGLS | |
| SCHEMBL22367610 | 0.84 | ALDH1A1 (0.44) | KDM4E | |
| SCHEMBL16141848 | 0.83 | TSHR (0.47) | KDM4EBCHEGLS | |
| SCHEMBL31267618 | 0.83 | ALDH1A1 (0.54) | KDM4E | |
| SCHEMBL3768879 | 0.83 | KDM4E (0.49) | MAOBNOS1NOS2PNMTENPP2 | |
| SCHEMBL3763398 | 0.81 | MAOB (0.44) | MAOBNOS1NOS2PNMTENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | MAOB 667/4885NOS1 2162/4885NOS2 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.